pramipexole has been researched along with j 113397 in 1 studies
| Studies (pramipexole) | Trials (pramipexole) | Recent Studies (post-2010) (pramipexole) | Studies (j 113397) | Trials (j 113397) | Recent Studies (post-2010) (j 113397) |
|---|---|---|---|---|---|
| 1,103 | 219 | 517 | 82 | 0 | 20 |
| Protein | Taxonomy | pramipexole (IC50) | j 113397 (IC50) |
|---|---|---|---|
| Mu-type opioid receptor | Homo sapiens (human) | 2.8 | |
| Kappa-type opioid receptor | Homo sapiens (human) | 1.5 | |
| Nociceptin receptor | Homo sapiens (human) | 0.0028 | |
| Mu-type opioid receptor | Cavia porcellus (domestic guinea pig) | 0.0023 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Marti, M; Morari, M; Viaro, R | 1 |
1 other study(ies) available for pramipexole and j 113397
| Article | Year |
|---|---|
Dual motor response to l-dopa and nociceptin/orphanin FQ receptor antagonists in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) treated mice: Paradoxical inhibition is relieved by D(2)/D(3) receptor blockade.
Topics: Amisulpride; Animals; Antiparkinson Agents; Benzimidazoles; Benzothiazoles; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Drug Interactions; Drug Synergism; Levodopa; Male; Mice; Mice, Inbred C57BL; Motor Activity; Neural Inhibition; Nociceptin; Opioid Peptides; Parkinsonian Disorders; Piperidines; Pramipexole; Pyridines; Reaction Time; Receptors, Dopamine D3; Sulpiride | 2010 |